Skip to main content
. 2023 Aug 17;108(6):589–598. doi: 10.1159/000527186

b.

Interventions

Comparison Study, n Patients, n
MTX 4 1,126
Tofacitinib 5 mg 1 373
Baricitinib 4 mg 1 159
Upadacitinib 15 mg 1 317
Filgotinib 200 mg 1 210

MTX, methotrexate; csDMARD, conventional synthetic disease-modifying antirheumatic disease; mTSS, modified total Sharp score.

a

DAS28-CRP < 2.6: Disease Activity Score in 28 joints using the C-reactive protein level.

b

DAS28-CRP ≤ 3.2.

c

DAS28-ESR < 2.6: DAS28 using the erythrocyte sedimentation rate.